PULSE BIOSCIENCES, INC. — Director's Dealing 2021

Jun 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2021-06-01

Reporting Person: Ebbers Ed (EVP & GM, Dermatology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-01	Common Stock	F	1485	$18.76	Disposed	39300	Direct

Footnotes

F1: Represents the total number of shares withheld by the Company to settle the Reporting Person's minimum tax liability pursuant to the contractual provisions of the June 2018 Restricted Stock Unit grant agreement previously disclosed.

F2: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.